Quote | Irras AB (OTCMKTS:IRRAF)
Last: | $0.6262 |
---|---|
Change Percent: | 0.0% |
Open: | $0.6262 |
Close: | $0.6262 |
High: | $0.6262 |
Low: | $0.6262 |
Volume: | 18,171 |
Last Trade Date Time: | 06/14/2021 04:41:36 am |
News | Irras AB (OTCMKTS:IRRAF)
IRRAS AB (publ) press release ( OTC:IRRAF ): Q4 GAAP EPS of -SEK0.06. Revenue of SEK10.6M (+47.2% Y/Y). For further details see: IRRAS AB (publ) GAAP EPS of -SEK0.06, revenue of SEK10.6M
IRRAS AB (publ) press release ( OTC:IRRAF ): Q3 GAAP EPS of -SEK0.34. Revenue of SEK11M (+80.3% Y/Y). For further details see: IRRAS AB (publ) GAAP EPS of -SEK0.34, revenue of SEK11M
Message Board Posts | Irras AB (OTCMKTS:IRRAF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Irras AB Company Name:
IRRAF Stock Symbol:
OTCMKTS Market:
IRRAS Announces publication of a Case report from Buffalo General Medical Center, highlights clinical superiority of IRRAflow treatment versus traditional drainage - IRRAflow Intraventricular Hemorrhage (IVH) Case Report Published in Cureus Journal of Medical Science - Publi...
IRRAS Announces Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery, to Advance Use of IRRAflow - The collaboration with Aarhus University's neurosurgical team will evaluate IRRAflow during the treatment of Intraventricular Hemorrhage (IVH) and ass...
IRRAS to Present at Redeye PR Newswire STOCKHOLM , March 23, 2021 /PRNewswire/ -- IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, today announced that company management will present at th...